CISPLATIN, INFLIXIMAB, IMFINZI 50 mg/mL concentrate for solution for infusion., GEMCITABINE, MYCOPHENOLATE MOFETIL
D933AC00001
Phase 3 small_molecule active
Quick answer
CISPLATIN, INFLIXIMAB, IMFINZI 50 mg/mL concentrate for solution for infusion., GEMCITABINE, MYCOPHENOLATE MOFETIL for First-line patients with advanced biliary tract cancers (BTC) is a Phase 3 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- First-line patients with advanced biliary tract cancers (BTC)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active